Market Research Future (MRFR) in its recently published study report asserts that the Global Wearable Injectors Market will exponentially grow further by 2023, registering approximately 15.2% CAGR throughout the forecast period (2018 – 2023).
Additional factors positively impacting the market growth include increasing cancer cases, the rising prevalence of chronic diseases, and growing uses of biologics. Also, technological advancements, improving outcomes and patients’ experience, beneficial reimbursement policies, and increasing awareness towards healthcare are some of the major driving forces pushing up the market growth.
On the other hand, factors such as the stringent government regulation and the time consuming, lengthy process for product approvals alongside the preference for traditional methods of drug delivery are negatively impacting the market growth. Nevertheless, factors such as the significant growth in the home healthcare are expected to support the market growth throughout the forecast period, pushing push up the demand for wearable injectors.
Wearable Injectors Market – Key Players
Some of the key players in the Global Wearable Injectors Market are West Pharmaceutical Services, Inc., Valeritas, Inc., Eli Lilly and Company, YPSOMED, Amgen Inc., Becton, Dickinson and Company (BD), CeQur SA, SteadyMed Therapeutics, Inc., BioSpace, Enable Injections, and Sensile Medical AG.
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/6491
February 08, 2019 – West Pharmaceutical Services, Inc. (the US), one of the world’s largest manufacturers and sellers of containment and delivery systems for injectable drugs and healthcare products announced its plans of partnering with Swissfillon AG (Switzerland), a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies for Clinical Filling of SmartDose® Drug Delivery Platform.
The partnership that is intended to lead to a non-exclusive global collaboration to provide fill-finish capabilities to customers using West’s proprietary SmartDose drug delivery platform for complex molecules. Through the collaboration, it is anticipated that West will be able to deliver an integrated solution with filled Daikyo Crystal Zenith® cartridges for the SmartDose wearable injector.
January 29, 2019 – scPharmaceuticals Inc. (the US), a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products announced its partnership with West Pharmaceutical Services, Inc. (the US), one of the world’s largest manufacturers and sellers of containment and delivery systems for injectable drugs and healthcare products to incorporate West’s SmartDose Drug Delivery System with the its (SC’s) lead drug FUROSCIX (furosemide), in development for treating edema in heart failure patients.
Wearable Injectors Market – Segmentation
For enhanced understanding, the report has been segmented into six key dynamics.
By Type: On-body, Off-body, and Hand-held Wearable Injectors.
By Usage: Disposable and Semi-reusable.
By Mechanism of Injection: Spring-based, Motor Driven, Rotary Pump, Expanding Battery, Pressurized Gas, and Collapsible Reservoir among others.
By Therapeutic Area: Oncology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, and Diabetes among others.
By End-user: Hospitals, Clinics, Homecare, and Ambulatory Surgery Centers among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Wearable Injectors Market – Regional Analysis
The market in the Americas is expected to dominate the global wearable injectors Market during the forecast period owing to the presence of well-established healthcare infrastructure and advanced technologies to administer drugs for the treatment of chronic diseases like diabetes. According to the National Diabetes Statistics Report 2017, an estimated 30.3 million people of all ages had diabetes in the US in 2015. The European market is expected to be the second-largest due to the growing medical devices industry in France, Germany & the UK and the rising opportunities for the market players. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to favorable government initiatives for the medical devices industry. The market in the Middle East & Africa is likely to account for the smallest share of the global wearable injectors market. The market growth in this region can be attributed to the rising research and development activities in the region.
Browse Complete 100 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/wearable-injectors-market-6491
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
+1 646 845 9312